Immunotherapy combined with primary resection of murine fibrosarcoma: correlation of immunological status of the host with prevention of metastases.
D000671:Amputation, Surgical; D000818:Animals; D000912:Antibodies, Neoplasm; D000936:Antigen-Antibody Complex; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D005354:Fibrosarcoma / Q000276:immunology* / Q000601:surgery; D006614:Hindlimb / Q000601:surgery; D007111:Immunity, Cellular; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000517:prevention & control; D008198:Lymph Nodes / Q000276:immunology*; D008297:Male; D008748:Methylcholanthrene; D051379:Mice; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000601:surgery; D009439:Neuraminidase / Q000627:therapeutic use; D013154:Spleen / Q000276:immunology*
D000912:Antibodies, Neoplasm; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D008748:Methylcholanthrene; D003165:Complement System Proteins; D009439:Neuraminidase